Thor Equities Group, a global leader in urban real estate development, leasing and management, is pleased to announce the acquisition of a three-building office campus in Rockville, MD.
Located in the Shady Grove Life Sciences Cluster, 20, 30, and 50 West Gude Drive, total over 231,000 square feet of space that supports a diversity of medical office, life science, office and technology uses over 17 acres.
“The properties in Shady Grove present a rare opportunity to acquire well-located assets with the potential to renovate and add value. The Washington D.C. market has performed strongly, and we believe that trend will continue,” said Executive Vice President of Thor Equities Group, Jack J. Sitt.
Thor’s current life science and R&D portfolio includes assets in premier clusters including New Jersey, San Jose, North Carolina’s RTP, and Boston. Thor’s assets in New Jersey include the first pre-built lab ready asset in Jersey City, 95 Greene Street, as well as The New Jersey Center of Excellence in Bridgewater, a 784,000-square-foot secure campus leased to anchor tenants Nestlé Health Science, Ashland, Amneal Pharmaceuticals, and PTC Therapeutics; and 7 Powder Horn Drive in Warren which is occupied by Celgene BMS. Thor also acquired an R&D asset leased to semiconductor developer NXP Semiconductors in San Jose in 2021.
Thor Equities launched its newly redesigned website, www.thorequities.com in November. The new website reflects the company’s status as a multi-dimensional asset manager and includes its Thor Ventures division focused on investing in technology, DTC brands and transformative businesses.